MRO & Manufacturing
Airbus Tests Exoskeletons to Boost Worker Safety and Efficiency
Airbus pilots industrial exoskeletons in global facilities to reduce physical strain by up to 40%, with plans to expand across aerospace manufacturing sites.
In the high-stakes world of aerospace manufacturing, precision, safety, and endurance are critical. Workers on final assembly lines perform physically demanding tasks that can lead to fatigue and musculoskeletal disorders (MSDs). To address these challenges, Airbus is testing industrial exoskeletons, wearable devices that support workers by reducing muscle strain and enhancing comfort. Once a sci-fi concept, exoskeletons are now being evaluated in Airbus facilities to protect workers and boost productivity.
Airbus’s pilot program is a data-driven, operator-focused initiative to integrate exoskeletons into manufacturing. With 118 units currently under evaluation in France, Spain, and Canada, and plans to expand to Germany, the UK, and the U.S., the program is setting a new standard for ergonomic innovation in aerospace.
Exoskeletons have progressed from bulky, powered devices in the early 2000s to lighter, passive systems today. Initially met with skepticism due to limited data and concerns about shifting pain points, their credibility has grown thanks to studies from organizations like INRS (France) and IRSST (Canada). These studies provide guidelines for safe deployment and highlight benefits like reduced muscle strain.
Airbus focuses on passive exoskeletons, which are mechanical, battery-free, and easier to integrate into workflows. These devices are lighter, more reliable, and cost-effective compared to powered exoskeletons. The pilot program tests their ability to relieve stress on shoulders, lumbar regions, and knees—areas most prone to strain in assembly line work.
Airbus’s medical team uses electromyography to measure muscle activity, alongside heart rate monitoring, to assess exoskeleton performance. In May 2025, a test showed a 10% to 40% reduction in shoulder and upper back muscular strain for paint shop operators sanding with exoskeletons. These operators, handling 2–3 kg sanders above their heads, reported less fatigue and discomfort.
Operators test exoskeletons for 2–3 months, performing tasks with and without the devices for comparison. Feedback is collected via questionnaires, ensuring the program remains operator-centric. According to Dr. Delphine Bouvet, who led the study, “These results confirm that an exoskeleton can in some cases provide support and comfort to the operator, all while reducing the arduousness of certain tasks such as sanding.”
“They confirm that an exoskeleton can in some cases provide support and comfort to the operator, all while reducing the arduousness of certain tasks such as sanding,” Dr. Delphine Bouvet, Airbus
Airbus tests exoskeletons tailored to specific tasks, such as sanding or fuselage assembly, focusing on support for shoulders, lumbar regions, or knees. This task-specific approach enhances effectiveness and user comfort. Use of exoskeletons is voluntary, considered a last resort when other ergonomic solutions—like task rotation or assistive devices—are insufficient, ensuring they complement existing workflows.
By involving operators in testing and feedback, Airbus refines the devices for better fit and usability, addressing issues like restricted movement or discomfort. This collaborative approach fosters acceptance and ensures the technology supports workers without disrupting production. Despite promising results, challenges remain. Some operators report discomfort from rigid frames or restricted mobility in tight spaces. The time needed to put on or remove exoskeletons (3–5 minutes) can also disrupt fast-paced assembly lines. Psychological barriers, such as perceptions of exoskeletons as “disability aids,” may lead to reluctance among some workers.
Airbus addresses these issues through a co-design approach, working with operators and ergonomists to improve device design and usability. Voluntary participation ensures exoskeletons are seen as supportive tools, not mandatory equipment, fostering greater acceptance.
Exoskeletons offer economic benefits by reducing injury-related costs, such as those from back or shoulder strain. Passive exoskeletons, with their lower cost and reliability, provide a viable solution for minimizing these expenses. As the manufacturing workforce ages—over 25% of EU manufacturing workers are over 50—exoskeletons could extend productive work life and reduce early retirement due to physical strain.
Airbus’s initiative could serve as a model for other industries, combining exoskeletons with other ergonomic tools like FlexTrack robots and zero-gravity arms to create safer, more efficient workplaces.
Airbus’s exoskeleton pilot program demonstrates how technology can enhance worker safety and efficiency. By focusing on passive, task-specific designs and prioritizing operator feedback, Airbus is pioneering ergonomic innovation in aerospace manufacturing. As the program expands and refines, it could drive broader adoption of exoskeletons, creating safer, more sustainable workplaces across industries.
What is an industrial exoskeleton? Are exoskeletons mandatory for Airbus workers? What types of tasks benefit most from exoskeleton use? How are exoskeletons tested at Airbus? What are the future plans for Airbus’s exoskeleton program?
Powering Production and Protecting People with Exoskeletons: Airbus’s Ergonomic Revolution
The Evolution of Industrial Exoskeletons
Scientific Backing and Ergonomic Benefits
Task-Specific Design and Voluntary Use
Challenges and the Road Ahead
Economic and Strategic Implications
Conclusion
FAQ
An industrial exoskeleton is a wearable device that supports specific body parts during physically demanding tasks, reducing muscle strain and preventing injuries.
No, Airbus’s exoskeleton program is voluntary, allowing operators to choose whether to use the devices for comfort and autonomy.
Tasks like sanding or fuselage assembly, involving repetitive overhead work or lifting, benefit most from exoskeleton support.
Each device is tested by a single operator for 2–3 months, with performance and physiological data collected and feedback gathered via questionnaires.
Airbus plans to expand testing to Germany, the UK, and the U.S., refining devices and planning for potential large-scale deployment.
Photo Credit: Airbus
MRO & Manufacturing
Rotortrade Secures Airbus H145D3 Helicopters for CareFlite EMS Fleet Upgrade
Rotortrade finalizes deal with CareFlite for two Airbus H145D3 EMS helicopters, including trade-in and leaseback of Bell 429s to maintain service during transition.
This article is based on an official press release from Rotortrade.
Global helicopters dealership Rotortrade has finalized a multifaceted fleet upgrade agreement with Texas-based emergency medical services (EMS) operator CareFlite. According to an official press release from Rotortrade, the transaction secures two 2024-built Airbus H145D3 helicopters for the non-profit air medical provider.
To facilitate the transition without disrupting CareFlite’s critical life-saving operations, the deal incorporates a trade-in and interim leaseback structure. Rotortrade accepted CareFlite’s existing Bell 429 helicopters as trade-in assets and is leasing them back to the operator until the new Airbus models enter service.
The aircraft are slated for delivery in April 2026, with official operational deployment expected by September 2026. This acquisition highlights a growing trend among EMS operators navigating extended manufacturing backlogs by leveraging the late-model pre-owned market.
CareFlite, founded in 1979 as a 501(c)(3) non-profit and recognized as the oldest joint-use air medical program in the United States, requires continuous operational readiness to serve North and Central Texas. To ensure no gaps in emergency coverage, Rotortrade structured a leaseback agreement for CareFlite’s current Bell 429 helicopters, allowing the operator to maintain its fleet capabilities during the transition period.
The logistical and technical requirements of the transaction were managed through Rotortrade’s global Maintenance, Repair, and Overhaul (MRO) network. Specifically, Rotortrade MRO Tallard in France and Rotortrade MRO Latrobe in the United States coordinated the necessary export and import procedures, alongside pre-purchase inspections, as detailed in the company’s announcement.
Financing and title transfers were facilitated through Insured Aircraft Title Services (IATS), with CareFlite independently managing its financing arrangements.
“By combining aircraft sales, asset trade-ins, interim leasing, and technical support… Rotortrade was able to structure a solution that supports CareFlite’s fleet modernization,” stated Philippe Lubrano, CEO of Rotortrade, in the press release.
Historically, CareFlite has relied heavily on Bell aircraft, including the Bell 429 and Bell 407GXi models. The shift to the Airbus H145D3 represents a notable evolution in the organization’s fleet strategy for advanced EMS operations. The two 2024-built Airbus H145D3 helicopters are specifically configured for air ambulance duties. According to the provided specifications, they feature Airbus Air Ambulance Technology (AAT) interiors and are fully equipped for scene response, interfacility transport, and Night Vision Goggle (NVG) missions.
We observe that this transaction is emblematic of broader structural challenges within the civil helicopter market. As highlighted in Rotortrade’s Global Helicopter Market Report 2026, released in March 2026, Original Equipment Manufacturers (OEMs) are currently grappling with constrained production capacities despite robust customer demand.
With delivery slots for certain new helicopter models extending between 42 and 48 months, operators are increasingly compelled to seek alternative procurement strategies. By acquiring reconfigured, late-model pre-owned aircraft, such as the 2024-built H145D3s in this agreement, EMS providers can significantly accelerate their fleet modernization timelines and bypass prolonged OEM wait times.
Furthermore, this deal underscores Rotortrade’s aggressive expansion into the competitive U.S. air medical sector. The CareFlite agreement follows closely on the heels of a March 11, 2026, announcement regarding the delivery of two 2023 Airbus H145D3s to Life Flight Network, signaling a deliberate strategic push by the dealership into the American EMS market.
When will CareFlite begin operating the new Airbus H145D3 helicopters? How is CareFlite maintaining service during the transition? Why are operators turning to the pre-owned helicopter market?
Structuring the Complex Fleet Upgrade
Maintaining Uninterrupted EMS Coverage
Aircraft Specifications and Strategic Shifts
Transitioning to the Airbus H145D3
Industry Context: Supply Chain Constraints
AirPro News analysis
Frequently Asked Questions
According to the transaction timeline, the aircraft will be delivered in April 2026 and are expected to officially enter operational service in September 2026.
Rotortrade accepted CareFlite’s existing Bell 429 helicopters as trade-ins and leased them back to the operator to serve as an interim fleet until the new aircraft are ready.
Industry data from Rotortrade’s 2026 market report indicates that new helicopter manufacturing faces severe backlogs, with wait times extending up to 48 months. Late-model pre-owned aircraft offer a faster route to fleet modernization.
Sources
Photo Credit: Rotortrade
MRO & Manufacturing
Blend Supply Named North American Master Distributor for Socomore Aerospace Chemicals
Blend Supply appointed as Socomore’s master distributor in North America to enhance aerospace chemical logistics and product availability starting April 2026.
On March 17, 2026, Texas-based Blend Supply announced it has been appointed as an Authorized Master Distributor for Socomore’s aerospace chemical portfolio across North America. According to the official press release, this partnership is designed to enhance logistics, product availability, and customer service for aerospace manufacturers, defense contractors, and airline maintenance organizations.
The agreement marks a strategic shift for Socomore toward a distributor-focused business model in the North American market, which will officially take effect on April 1, 2026. By leveraging Blend Supply’s established nationwide logistics network, the companies aim to streamline procurement and ensure rapid inventory fulfillment for critical aerospace operations.
The transition to a distributor-focused model highlights a growing emphasis on supply-chain optimization within the aerospace sector. Under the new agreement, Blend Supply will utilize its network of six distribution centers across the United States to provide dedicated sales support, procurement assistance, and consolidated purchasing options for Socomore’s clients.
Tom Bell, Vice President of Sales for North America at Socomore, emphasized the logistical advantages of the new arrangement in the company’s press release, noting the importance of maintaining consistent access to essential manufacturing materials.
“Blend Supply’s aerospace expertise, logistics capabilities, and customer focus make them an ideal partner to support our North American distribution strategy. This partnership ensures our customers continue to receive reliable access to the technologies they depend on for aircraft manufacturing and maintenance.” Through this master distribution agreement, Blend Supply will manage the distribution of several globally recognized aerospace chemical technologies manufactured by Socomore. The French-headquartered company, which has operated in the aerospace sector since 1972, produces specialty chemicals that meet over 1,000 different aerospace specifications from global original equipment manufacturers (OEMs), including Airbus.
The distributed portfolio includes critical surface pretreatment systems like PreKote®, sol-gel adhesion promoters such as Socogel®, and aerospace protective coatings under the Chemglaze® and Aeroglaze® brands. Additionally, the agreement covers aviation paint strippers (Sea to Sky®), cleaning solvents (DieStone® and Dysol®), sealant removal tools (Elixair®), and pre-saturated surface preparation wipes (Socowipes®).
Clint Broadie, President of Blend Supply, noted the importance of reliable access to these specialized products for the aviation industry.
“These technologies are deeply embedded in aerospace manufacturing and maintenance operations around the world. Our role as an Authorized Master Distributor ensures customers have a reliable, well-stocked source backed by the logistics, service, and technical expertise required in aerospace operations.” We observe that Socomore’s shift to a regional master distributor model reflects a broader aerospace industry trend. Chemical manufacturers are increasingly relying on specialized distributors to navigate complex warehousing and localized customer support. This strategy helps ensure that critical maintenance chemicals are readily available, thereby minimizing costly aircraft downtime for Maintenance, Repair, and Operations (MRO) facilities and airlines. Furthermore, the partnership aligns with ongoing sustainability and Health, Safety, and Environment (HSE) initiatives within the aviation sector. Corporate data indicates that Socomore is heavily invested in its “Socomore 2030” initiative, prioritizing decarbonization and reduced environmental impact. For instance, products like the DieStone DLV cleaning solvent are engineered to reduce Volatile Organic Compounds (VOCs) by up to 30% compared to traditional alternatives. The inclusion of biodegradable solvents, such as Dysol, in the Blend Supply distribution agreement underscores the industry’s necessary push toward greener maintenance practices.
Socomore’s transition to a distributor-focused model with Blend Supply in North America officially begins on April 1, 2026.
The partnership is focused on the North American market, serving aerospace manufacturers (OEMs), airline maintenance organizations, MRO facilities, defense contractors, and advanced manufacturing operations.
Sources: PR Newswire
Blend Supply Named North American Master Distributor for Socomore Aerospace Chemicals
Partnership Details and Strategic Shift
Streamlining the Aerospace Supply Chain
Expanding Access to Critical Chemical Technologies
Comprehensive Product Portfolio
Industry Context and Sustainability Goals
AirPro News analysis
Frequently Asked Questions
When does the new distribution agreement take effect?
What markets will this partnership serve?
Photo Credit: Blend Supply
MRO & Manufacturing
Airbus Seeks Damages from Pratt & Whitney Over Engine Delays
Airbus has lowered 2026 delivery targets and delayed A320neo production due to Pratt & Whitney’s delayed engine shipments following a 2023 recall.
This article summarizes reporting by Reuters
Airbus is escalating a months-long supply chain dispute with U.S. engine manufacturer Pratt & Whitney, pursuing financial damages over delayed engine shipments. According to reporting by Reuters, the European planemaker has officially triggered a claim against the RTX Corporation subsidiary, highlighting a severe bottleneck in commercial aerospace manufacturing.
The conflict centers on the allocation of Pratt & Whitney’s Geared Turbofan (GTF) engines. Airbus alleges that the supplier is prioritizing maintenance, repair, and overhaul (MRO) shops to fix grounded aircraft rather than delivering new engines to Airbus assembly lines. This shortage has directly impacted Airbus’s bottom line and production capabilities.
Consequently, Airbus has been forced to cut its 2026 aircraft delivery forecasts and delay its production ramp-up goals for the best-selling A320neo family. The situation underscores a broader industry tension between aircraft manufacturers demanding parts for new planes and airlines demanding parts to keep their existing fleets operational.
The current supply bottleneck traces back to a major manufacturing defect discovered in 2023. Pratt & Whitney had to issue a recall for certain PW1000G engine models due to contaminated powdered metal used to produce specific engine parts. This recall and the subsequent mandatory inspections left hundreds of aircraft grounded globally, creating a massive backlog for MRO services.
The aerospace industry is still recovering from post-pandemic supply chain disruptions, making it difficult for suppliers to rapidly scale up the production of replacement parts and new engines simultaneously. Pratt & Whitney’s GTF engines are critical to Airbus operations, powering approximately 40 percent of the highly popular A320neo family of narrowbody jets and exclusively powering the Airbus A220.
The dispute has evolved into a “tug of war” over scarce engine supplies. Airbus claims that Pratt & Whitney over-promised on engine shipments for 2026 and is now backtracking on its contractual commitments by diverting engines and spare parts away from new jets.
Conversely, airlines have largely sided with the engine maker’s prioritization of repairs. According to the provided research, Lufthansa’s CEO publicly defended Pratt & Whitney, arguing that keeping existing carrier fleets operational should take priority over the production of new aircraft. Engine manufacturers also typically generate the majority of their long-term revenue from aftermarket repairs and maintenance, adding financial weight to the MRO prioritization. The engine shortage has caused tangible disruptions to Airbus’s manufacturing and financial targets. Due to the lack of engines, Airbus was forced to reduce its 2026 commercial aircraft delivery target to 870 planes. While this is an increase from the 793 planes delivered in 2025, it falls short of the roughly 907 deliveries industry analysts had expected for 2026.
Furthermore, Airbus has delayed its production ramp-up goals. The company had previously aimed to produce 75 A320neo family jets per month by 2026 or early 2027. Because of the engine shortages, Airbus now expects to reach a rate of 70 to 75 aircraft per month by the end of 2027, stabilizing at 75 thereafter.
Tensions boiled over publicly during Airbus’s fiscal year 2025 earnings presentation on February 19, 2026. During the call, Airbus CEO Guillaume Faury publicly criticized the supplier, warning that Airbus was ready to enforce its contractual rights.
“failure to commit to the number of engines ordered by Airbus is negatively impacting this year’s guidance and the ramp-up trajectory”
, Airbus CEO Guillaume Faury, speaking during the February 2026 earnings call.
On March 19, 2026, Reuters reported that Airbus officially triggered a claim seeking unspecified financial damages from Pratt & Whitney. While the exact venue for the dispute has not been publicly confirmed, international commercial claims in the aerospace sector are typically handled through confidential arbitration proceedings.
We observe that this escalation marks a significant hardening in one of aviation’s most critical supplier relationships. The dynamic between planemakers, engine suppliers, and airlines is highly fragile in a capacity-constrained market. Late engine deliveries result in completed airframes waiting on the tarmac without engines, often referred to in the industry as “gliders.” This ties up the manufacturer’s cash flow and delays revenue recognition, as airlines pay the bulk of an aircraft’s purchase price upon final delivery.
If Airbus is successful in securing compensation, it could set a major legal precedent. Other aircraft manufacturers may be emboldened to push the financial costs of supply chain disruptions back onto their suppliers, which would raise legal and warranty risks across the entire aerospace sector. We will continue to monitor RTX Corporation’s upcoming financial disclosures to see if they provision funds for potential legal payouts or arbitration settlements related to this dispute.
Airbus alleges that Pratt & Whitney is failing to meet its contractual engine delivery commitments for 2026, prioritizing repair shops for grounded aircraft over supplying engines for new Airbus assembly lines. Airbus has lowered its 2026 delivery guidance to 870 commercial aircraft and delayed its goal of producing 75 A320neo family jets per month until the end of 2027.
In 2023, Pratt & Whitney issued a recall for certain PW1000G engine models due to contaminated powdered metal used in specific parts. This grounded hundreds of aircraft and created a massive backlog for maintenance and repairs.
Sources: Reuters
The Root of the Engine Dispute
The 2023 Recall and Supply Chain Strain
Competing Priorities: New Builds vs. Repairs
Financial and Operational Impacts on Airbus
Lowered Guidance and Delayed Ramp-Up
Escalation to Damages
AirPro News analysis
Frequently Asked Questions
Why is Airbus seeking damages from Pratt & Whitney?
How has the engine shortage affected Airbus’s production?
What caused the initial Pratt & Whitney engine shortage?
Photo Credit: Airbus
-
MRO & Manufacturing2 days agoAirbus Seeks Damages from Pratt & Whitney Over Engine Delays
-
Technology & Innovation7 days ago3M Partners with JetZero to Develop Fuel-Efficient Blended-Wing Airliner
-
Business Aviation6 days agoJet Air Expands Midwest Presence with Revv Aviation Acquisition
-
MRO & Manufacturing4 days agoRyanair Opens €25M Maintenance Hangar at Madrid Barajas Airport
-
Defense & Military3 days agoKongsberg Secures NOK 2 Billion Contract Extension for F-35 Components
